The Jackson Laboratory Cancer Center (JAXCC) is an organizational unit with dedicated administrative oversight that is strategically integrated with the parent organization's administration. Dr. Edison Liu, JAXCC Director, heads the Cancer Center administration, working with other members ofthe JAX executive committee, the Senior Management Team;Drs. Braun, (Center Deputy Director), Donahue (Director of Genetic Resource Science and co-Project Leader Cancer Models Development Resource) and Hewett (JAX Executive Vice President and Chief Operating Officer). Dr. Barbara Tennent, Associate Director for Research Administration provides dedicated administrative support to the JAXCC and reports to Dr. Liu. Two committees comprise the formal administrative structure ofthe JAXCC. The Operations Committee, chaired by Dr. Liu comprises Drs. Braun, Hewett, Nair and Tennent, and works to ensure that the overall direction ofthe JAXCC operations anticipates and supports the needs of JAXCC members. The Shared Resources Management Committee, which comprises Ms. Valerie Scott, Senior Director of Scientific Services, Ms. Yu-Hui Rogers, Site Director, JAX Genomic Medicine, and Drs. Donahue and Tennent coordinate the operations and development of CCSG-supported shared resources across campuses. Funds are requested for partial support of Dr. Tennent's administrative responsibilities. She oversees the necessary planning, policy development, budget development and research developmental activities for the ongoing growth ofthe JAXCC cancer research focus. Dr. Tennent is the primary coordinator for scientific and administrative management of the JAXCC. She is an ex officio member of the Scientific Executive Committee and serves on the Operations Executive Committee and the Shared Resources Committee. She works closely with all members ofthe administrative team to coordinate the activities ofthe JAXCC, including organization of the External Advisory Board meetings, management ofthe pilot project process, and membership records. Dr. Tennent is the primary administrative contact for NCI Cancer Center program officials and is responsible for management ofthe renewal, progress reports and requests from NCI as required. Institutional funds support dedicated effort for Ms. Scoff, who oversees the four institutional scientific services for which CCSG support is requested. She is responsible for advocacy, policy development and application, budget management, operations, quality assurance, technical staffing and development, planned technology acquisition and implementation as well as user communications. Institutional funds also support Ms. Roger's together in implementing processes, procedures and management structure that facilitate efficient resource sharing and access to CCSG-supported resources. The JAXCC is strongly supported by institutional administrative offices including the Office of Sponsored Programs for pre and post award administration, compliance, and financial management of the CCSG;Financial Services for budget development and account management;and Scientific Program Development, for securing external funding from foundations and federal agencies for research, education, and resource programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA034196-29
Application #
8699303
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2019-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
29
Fiscal Year
2014
Total Cost
$92,561
Indirect Cost
$39,669
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Jung, Seung-Hyun; Kim, Min Sung; Lee, Sung-Hak et al. (2016) Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. Proc Natl Acad Sci U S A 113:10672-7
Qin, Wenning; Kutny, Peter M; Maser, Richard S et al. (2016) Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing. Curr Protoc Mouse Biol 6:39-66
Tai, Derek J C; Ragavendran, Ashok; Manavalan, Poornima et al. (2016) Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci 19:517-22
Sundberg, John P; Pratt, C Herbert; Silva, Kathleen A et al. (2016) Dermal lymphatic dilation in a mouse model of alopecia areata. Exp Mol Pathol 100:332-6
Parvanov, Emil D; Tian, Hui; Billings, Timothy et al. (2016) PRDM9 interactions with other proteins provide a link between recombination hotspots and the chromosomal axis in meiosis. Mol Biol Cell :
Ali, Riyasat; Babad, Jeffrey; Follenzi, Antonia et al. (2016) Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease. Immunology 148:339-51
Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan et al. (2016) Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation. Elife 5:
Jangalwe, Sonal; Shultz, Leonard D; Mathew, Anuja et al. (2016) Improved B cell development in humanized NOD-scid IL2Rγ(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun Inflamm Dis 4:427-440
Korstanje, Ron; Deutsch, Konstantin; Bolanos-Palmieri, Patricia et al. (2016) Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria. J Am Soc Nephrol 27:3271-3277
Samanta, S; Sun, H; Goel, H L et al. (2016) IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG. Oncogene 35:1111-21

Showing the most recent 10 out of 958 publications